What Is an FDA Form 483?

What a Form 483 means, and what it does not mean, is frequently misunderstood by teams encountering one for the first time.

What the Form Actually Is

Under 21 U.S.C. 374 (Section 704 of the FD&C Act), FDA may enter and inspect establishments that manufacture devices, drugs, or other regulated products. Section 704(b) requires the inspecting officer, before leaving the premises, to give the firm a written report of certain conditions or practices observed. FDA uses the Form 483 for this purpose, and describes it as issued when an investigator has observed conditions that, in the investigator's judgment, may constitute violations of the FD&C Act and related Acts.

The observations are also not described by FDA as a comprehensive record of everything found during the inspection; they are the specific conditions the investigator chose to document on the form itself.

Who Issues It, and When

An FDA investigator issues the Form 483 directly to the firm, typically presented and discussed at the closeout meeting at the end of the inspection. It is issued in the field, by the investigator conducting the inspection, not by FDA headquarters after review.

What a Form 483 Is Not

• Not a final agency determination. FDA's actual decision on whether a violation occurred, and what action if any to take, happens later, after FDA reviews the firm's written response and any supporting evidence.
• Not a Warning Letter. A Warning Letter is a distinct, more serious enforcement action FDA issues when it concludes a firm's response to a 483 was inadequate, or when the violations are significant enough on their own to warrant formal notice. Warning Letters are also posted publicly on FDA's website; Form 483s are not routinely published at the time of issuance.
• Not evidence the quality system has failed overall. One or more observations do not by themselves establish that a facility is out of compliance across the board.

What an Observation Looks Like

Each item on a Form 483 states the specific condition or practice the investigator observed, usually tied to a particular quality system requirement under 21 CFR Part 820 (the QMSR as of February 2026) or another applicable regulation. A form can carry a single observation or many, and each is numbered and described independently. There is no agency-assigned severity rating printed on the form itself, though some observations plainly carry more risk than others.

The Response Window That Follows

No statute or regulation sets a deadline for responding to a Form 483. The 15 business day convention comes from FDA itself: in a program announced in 2009, the agency said it will generally not delay a Warning Letter decision to consider a response received more than 15 business days after the Form 483 was issued. A written response inside that window is therefore the standard target.

A complete response addresses root cause, correction, corrective action, and supporting evidence for every observation.

ADB's regulatory team reviews Form 483 observations against FDA's expectations and helps manufacturers build that response. The full structure of a complete response is covered in How Do I Respond to an FDA Form 483 Within 15 Business Days?

Frequently Asked Questions

Is a Form 483 a final FDA determination?

No. A Form 483 is the investigator's own observations at the close of an inspection. FDA's actual determination of what action, if any, to take comes later, after FDA reviews the firm's response and any follow-up evidence.

Is a Form 483 the same as a Warning Letter?

No. A Form 483 lists an investigator's observations; a Warning Letter is a more serious enforcement escalation FDA issues when it concludes a firm's response was inadequate or the violations are significant enough to warrant formal notice. A Warning Letter is also posted publicly on FDA's website.

Does getting a Form 483 mean my facility failed the inspection?

Not necessarily. A Form 483 records an investigator's observations and is not a final agency determination. What FDA does next depends in large part on the firm's response.

Who issues a Form 483 and under what authority?

An FDA investigator issues the Form 483 at the close of an establishment inspection conducted under Section 704 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374), which authorizes FDA to inspect regulated establishments. FDA issues the form when an investigator observes conditions that, in the investigator's judgment, may constitute violations.

How long does a firm have to respond to a Form 483?

There is no statutory or regulatory deadline. FDA has said it will generally consider a response received within 15 business days of the Form 483 being issued before it decides whether to issue a Warning Letter, so 15 business days is the standard target.